Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 131-140 of 307 for infectious diseases

Edit search filters
  1. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection

    Rochester, MN

  2. A Study for the Use of Hepatitis C Virus Seropositive Donors into Hepatitis C Seronegative Liver Transplant Recipients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease

    Scottsdale/Phoenix, AZ

  4. A Study To Evaluate the Effectiveness, Safety, And Tolerability of a Clostridium Difficile Vaccine In Adults 50 Years of Age and Older

    Rochester, MN

  5. Allogeneic Transplant in HIV Patients (BMT CTN 0903)

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. "Less Pain, Less Fuss, Right Now!" and "Make It Count!"- Efforts to Enhance Provider Recommendations for HPV Vaccination

    Rochester, MN

  7. A Study of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection

    Jacksonville, FL, Rochester, MN

  8. Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin In Subjects With Chronic HCV With Advanced Liver Disease Or Post-Liver Transplant

    Jacksonville, FL

  9. Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN, La Crosse, WI, Eau Claire, WI

  10. A Study To Evaluate The Efficacy And Safety Of A Vaccine, ASP0113, In Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving An Organ From A CMV-Seropositive Donor

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer